The FDA granted emergency use authorization to Novavax’s Covid-19 vaccine. In a trial of more than 26,000 adults, 2 doses of the Novavax Covid vaccine were over 90% effective at preventing symptomatic disease and presented no serious side effects.
The Food and Drug Administration on Wednesday granted emergency use authorization to Novavax’s Covid-19 vaccine, opening up another option for adults who have not received immunization against the virus.
Novavax executives have said they hope the shot will see uptake in individuals who have expressed hesitancy toward other Covid-19 vaccines or are allergic to components of the others’ ingredients.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: